
Limiting PSA screening to symptomatic men under 70 with a comprehensive risk-based approach can reduce overdiagnosis and overtreatment in prostate cancer detection.


coremsg

A new strategy that would limit screening for prostate cancer to men under 70 who are at risk or symptomatic would reduce the potential harm from overdiagnosis and overtreatment, an international panel recommends.

Limit PSA Screening to Men With Symptoms

limit-psa-screening-to-men-with-symptoms-a-comprehensive-risk-based-approach


Limit PSA Screening to Men With Symptoms: A Comprehensive Risk-Based Approach
